| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |